10/22/24 17:13 | 10/18/24 | TYRA | Tyra Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | P,CEO | S.m | -1,711 | 27.28 | 0 | -63 | -4 | 1,356 | D | | | | | | | | | | | | | | |
10/17/24 20:12 | 10/15/24 | TYRA | Tyra Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | P,CEO | S.m | -1,513 | 25.77 | 0 | -59 | -4 | 1,419 | D | | | | | | | | | | | | | | |
10/2/24 17:38 | 9/30/24 | TYRA | Tyra Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | P,CEO | S | -12 | 24.00 | 0 | -1 | 0 | 1,477 | D | | | | | | | | | | | | | | |
9/25/24 18:44 | 9/23/24 | TYRA | Tyra Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | P,CEO | S.m | -283 | 24.11 | 0 | -12 | -1 | 1,478 | D | | | | | | | | | | | | | | |
9/20/24 18:24 | 9/18/24 | TYRA | Tyra Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | P,CEO | S.m | -394 | 24.19 | 0 | -16 | -1 | 1,490 | D | | | | | | | | | | | | | | |
2/6/24 20:22 | 2/2/24 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | P,CEO | S.m | -1,656 | 16.56 | 0 | -100 | -6 | 1,503 | D | | | | | | | | | | | | | | |
6/26/23 19:30 | 6/22/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | S.m | -412 | 17.01 | 0 | -24 | -1 | 1,601 | D | | | | | | | | | | | | | | |
6/21/23 20:16 | 6/16/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | S.m | -1,298 | 17.12 | 0 | -76 | -4 | 1,625 | D | | | | | | | | | | | | | | |
6/15/23 21:00 | 6/13/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | M.dm | 47 | 2.25 | 0 | 21 | 1 | 1,701 | D | | | | | | | | | | | | | | |
6/15/23 21:00 | 6/13/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | S.dm | -333 | 16.08 | 0 | -21 | -1 | 1,701 | D | | | | | | | | | | | | | | |
4/5/23 17:20 | 4/3/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | M.d | 5 | 2.25 | 0 | 2 | 0 | 1,701 | D | | | | | | | | | | | | | | |
4/5/23 17:20 | 4/3/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | S.d | -32 | 16.13 | 0 | -2 | 0 | 1,701 | D | | | | | | | | | | | | | | |
3/31/23 19:02 | 3/29/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | M.dm | 10 | 2.25 | 0 | 4 | 0 | 1,701 | D | | | | | | | | | | | | | | |
3/31/23 19:02 | 3/29/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | S.dm | -70 | 16.07 | 0 | -4 | 0 | 1,701 | D | | | | | | | | | | | | | | |
3/28/23 19:09 | 3/24/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | M.dm | 13 | 2.25 | 0 | 6 | 0 | 1,701 | D | | | | | | | | | | | | | | |
3/28/23 19:09 | 3/24/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | S.dm | -95 | 16.00 | 0 | -6 | 0 | 1,701 | D | | | | | | | | | | | | | | |
3/23/23 19:49 | 3/21/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | M.dm | 43 | 2.25 | 0 | 19 | 1 | 1,701 | D | | | | | | | | | | | | | | |
3/23/23 19:49 | 3/21/23 | TYRA | Tyra Biosciences, Inc. | | Health | Drug | Pharmaceutical Preparations | Harris Todd | CA | DO | CEO | S.dm | -308 | 16.00 | 0 | -19 | -1 | 1,701 | D | | | | | | | | | | | | | | |